Heart Pump Devices Market Report 2026

Heart Pump Devices Market Overview

• Heart Pump Devices market size has reached to $4.48 billion in 2025 • Expected to grow to $10.37 billion in 2030 at a compound annual growth rate (CAGR) of 18.1% • Growth Driver: Increasing Prevalence Of Cardiovascular Disorders • Market Trend: Medtronic Launches VitalFlow ECMO System to Enhance Life Support for Severe Heart and Lung Conditions • North America was the largest region in 2025.

What Is Covered Under Heart Pump Devices Market?

A heart pump device is a mechanical support device that helps to pump blood from the chambers of the heart to the rest of the body. It is used to temporarily help the pumping action of the heart. The main types of heart pump devices are implantable heart pump devices and extracorporeal heart pump devices. Implantable heart pump devices are mechanical pumps which is implanted in the chest of a person to help a weakened heart pump blood. The various therapy includes bridge-to-transplant (BTT), bridge-to-candidacy (BTC), destination therapy (DT) and others, and are used by various end-users such as hospitals, ambulatory surgical centers, specialty clinics and others.

What Is The Heart Pump Devices Market Growth Forecast?

The heart pump devices market size is expected to see rapid growth in the next few years. It will grow to $10.37 billion in 2030 at a compound annual growth rate (CAGR) of 18.1%. The growth in the forecast period can be attributed to increasing demand for long-term circulatory support, rising adoption of destination therapy devices, expansion of minimally invasive cardiac procedures, growing integration of smart monitoring technologies, increasing investments in advanced cardiac care. Major trends in the forecast period include increasing use of advanced ventricular assist devices, rising adoption of temporary mechanical circulatory support, growing focus on miniaturized implantable pumps, expansion of bridge-to-transplant therapies, enhanced monitoring of hemodynamic performance.

Global Heart Pump Devices Market Segmentation

1) By Type: Implantable Heart Pump Devices, Extracorporeal Heart Pump Devices 2) By Therapy: Bridge-To-Transplant (BTT), Bridge-To-Candidacy (BTC), Destination Therapy (DT), Other Therapies 3) By End-user: Hospitals, Cardiac Specialty Hospitals / Heart Centers, Transplant Centers, Other End-Users Subsegments: 1) By Implantable Heart Pump Devices: Left Ventricular Assist Devices (LVADs), Right Ventricular Assist Devices (RVADs), Biventricular Assist Devices (BiVADs), Total Artificial Hearts (TAHs) 2) By Extracorporeal Heart Pump Devices: Intra-Aortic Balloon Pumps (IABPs), Ventricular Assist Devices (Temporary): Centrifugal Blood Pumps

What Is The Driver Of The Heart Pump Devices Market?

The increasing prevalence of cardiovascular disorders is expected to propel the heart pump devices market going forward. Cardiovascular disorders refer to a term for the conditions affecting the heart or blood vessels. The rise in cardiovascular diseases would require advanced diagnostics and treatments such as heart pump devices that help pump blood from the lower left heart chamber that is used to help maintain blood flow during high-risk protected percutaneous coronary interventions, which would increase the demand for the market. For instance, in January 2024, according to the American Heart Association, a US-based non-profit organization, the age-adjusted death rate from cardiovascular disease increased to 233.3 per 100,000 in 2024 up 4.0% from 224.4 per 100,000 in 2023. Therefore, the increasing prevalence of cardiovascular disorders is driving the growth of the heart pump devices industry.

Key Players In The Global Heart Pump Devices Market

Major companies operating in the heart pump devices market are Abbott Laboratories, Medtronic plc, Getinge AB, Terumo Corporation, LivaNova plc, SynCardia Systems Inc, CARMAT SA, Jarvik Heart Inc, BiVACOR Inc, CorWave SA, Fresenius Kabi AG, Asahi Kasei Medical Co Ltd, Nipro Corporation, Eurosets Srl, CardioBridge GmbH, Hemovent GmbH, Evaheart Inc, Calon Cardio-Technology Ltd, Lepu Medical Technology Co Ltd, NewHeart Technologies Inc

Global Heart Pump Devices Market Trends and Insights

Major companies operating in the heart pump devices market are developing extracorporeal membrane oxygenation (ECMO) systems to provide advanced life support for patients with severe heart and lung conditions. Extracorporeal membrane oxygenation (ECMO) systems refer to advanced life support machines used to provide prolonged cardiac and respiratory support for patients whose heart and lungs are unable to function properly. For instance, in September 2024, Medtronic plc, an Ireland-based medical device company, launched VitalFlow system, an innovative extracorporeal membrane oxygenation (ECMO) solution designed to provide circulatory support for patients with severe heart or lung failure. The VitalFlow system functions as a heart pump by using a pump and oxygenator to take over the work of the heart and lungs. This is crucial for patients experiencing life-threatening conditions, allowing their organs to rest and heal.

What Are Latest Mergers And Acquisitions In The Heart Pump Devices Market?

In May 2023, BioForum Inc., a US-based healthcare technology company, partnered with Abiomed Inc. to enhance cardiovascular care solutions. With this partnership, BioForum Inc., aims to provide Abiomed with streamlined, high-quality clinical trial data management and analytics services, enhancing operational efficiency, accelerating regulatory submissions, and supporting real-world evidence generation. Abiomed Inc.is a US-based healthcare technology company that specializes in developing and manufacturing percutaneous and surgical heart pump systems to improve patient outcomes in heart failure and other circulatory conditions.

Regional Outlook

North America was the largest region in the heart pump devices market share in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Heart Pump Devices Market?

The heart pump devices market consists of sales of pacemakers, biventricular devices, cardioverter defibrillators, and mechanical assist devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.